Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Humacyte, Inc., a Nasdaq-listed biotech company specializing in bioengineered human tissues, announced the appointment of Dr. Todd E. Rasmussen, a distinguished vascular surgeon, as Chief Surgical Officer. Dr. Rasmussen brings extensive clinical expertise and leadership to support the clinical use and adoption of Humacyte’s flagship product Symvess…
Daré Bioscience announced encouraging interim results from its ongoing Phase 3 clinical trial for Ovaprene®, a hormone-free, intravaginal monthly contraceptive. The Data Safety Monitoring Board recommended continuing the study without modification, confirming Ovaprene's safety profile and contraceptive efficacy consistent with company expectations.…
Rezolve Ai (NASDAQ: RZLV) announced a strategic global partnership with Tata Consultancy Services (TCS), a major IT services leader with $30bn+ revenue. Under the agreement, TCS will resell Rezolve's AI-powered commerce platform to its extensive enterprise client base, expanding Rezolve's global market reach and accelerating adoption of its AI-nati…
ABM Industries Incorporated, a leading provider of facility, engineering, and infrastructure solutions, announced it received the 2026 IABC Gold Quill Award of Excellence in recognition of its enterprise-wide brand transformation. The company has strategically repositioned itself from a commoditized service provider to a consultative partner delive…
Kalaris Therapeutics reported progress in its Phase 1b/2 clinical study of TH103 for neovascular age-related macular degeneration, with patient screening underway and new clinical material batches manufactured. Preliminary data is anticipated in the first half of 2027, and Phase 3 trials remain on track for year-end 2027 initiation. As of March 31,…
PMV Pharmaceuticals announced its first quarter 2026 financial results and key corporate updates, highlighting progress in the development of rezatapopt, a first-in-class p53 reactivator for TP53 Y220C mutated cancers. The company reported on-track enrollment in the registrational Phase 2 PYNNACLE study, upcoming NDA submission scheduled for early …
Eagle Bancorp, Inc., a prominent community bank holding company in the Washington, D.C. area, announced the appointment of Stephen Curley as president and CEO effective July 6, 2026. Curley brings over 25 years of banking experience and a strong track record in commercial banking, deposit growth, capital allocation, and risk management. The leaders…
Immuneering (IMRX) has a visible binary catalyst at the end of the month tied to updated clinical data for atebimetinib (IMM-1-104). The market already prices a polarized outcome: strong upside if survival holds and the program continues to de-risk toward Phase 3; sharp downside if data disappoints. With a $336.8M market cap, strong recent institut…
Bank of America has reinstated coverage of Autodesk with a Buy rating and set a $300 price target, citing the company’s proprietary 3D data, long-term AI investment, and the specialized nature of design-focused AI as defensive advantages. The bank projects revenue growth in the low double digits and rising free cash flow, while noting near-term exe…
eToro reported an adjusted profit above analyst expectations for the first quarter, driven by a pronounced increase in commodities trading activity. The retail trading platform recorded a sharp rise in net trading contribution across equities, commodities and currencies, and introduced around-the-clock trading for several asset classes during the q…
Hims & Hers Health Inc. stock dropped sharply after the company reported first-quarter results that missed Wall Street expectations on both revenue and adjusted EBITDA. Revenue rose modestly year-over-year but fell short of consensus and BTIG estimates, while adjusted EBITDA declined dramatically versus the prior year, prompting analyst concerns ab…
NICE plunged after a Q1 earnings miss on 05/06/2026 but still shows durable cloud and AI-driven revenue trends. Market cap sits at $5.47B with a PE of 10.7 and a deep technical oversold setup. This trade targets a recovery to $130 over the next 180 trading days with a tight stop below the new 52-week low to limit downside if enterprise demand softe…
Diana Shipping Inc., a public US-listed dry bulk shipping company, has launched www.CashforGenco.com to support its campaign to elect six independent directors to Genco Shipping & Trading's board. Diana owns approximately 14.7% of Genco and has made an all-cash acquisition offer of $23.50 per share, representing a 31% premium. Diana highlights alle…
Premiums for Russia's Urals crude destined for Indian ports have fallen for June delivery as refiners cut back purchases in response to weakening refining margins. The margin-driven pullback has trimmed Urals' premium to Brent to $2-$4 a barrel from $6-$7 for May cargoes, while similar softening is visible for Russia's ESPO Blend shipments to China…
Under Armour Inc. shares tumbled 13.75% in pre-market trading after the company released unaudited results for fiscal 2026 and issued fiscal 2027 guidance that fell well short of analyst expectations. Management guided adjusted EPS of $0.08 to $0.12 for fiscal 2027 and forecast slightly lower revenue, while extending a restructuring program that ra…
Goldman Sachs estimates that global spending on non-hardware aspects of artificial intelligence - including data infrastructure, software and organizational redesign - could exceed $1 trillion in the coming years. The bank highlights current U.S. labor costs tied to the AI transition at $150 billion per year, plus $40 billion annually in executive …
ZenaTech announces the establishment of Phoenix Aero LLC in Lviv, Ukraine, as a manufacturing hub for AI-enabled counter-UAS and interceptor drones aimed at Gulf Cooperation Council defense customers. The initiative leverages cost-effective production and real-world testing to meet growing Middle Eastern demand for scalable, affordable defense dron…
Shares of several publicly traded quantum computing companies climbed after Quantum Computing reported first-quarter 2026 results that showed sharply higher revenue driven by recent acquisitions, a wider operating loss and an expanded contract backlog. The results prompted gains in peer stocks including Rigetti, IonQ and D-Wave Quantum.
U.S. equity futures were softer in early Tuesday trading as investors reacted to intensifying tensions in the Middle East and awaited key inflation figures. Premarket movers included sharp declines for GameStop and Hims & Hers Health after deal and earnings disappointments, while Aramark climbed following stronger-than-expected revenue.
New data from MSCI indicates that over 10% of loans held by private credit funds have been marked down by at least 50%, a level MSCI associates with deep borrower distress or imminent restructuring. The report points to a sustained period of relatively high interest rates as a contributing factor. Writedowns are highest since the post-COVID-19 peri…
POET Technologies Inc. named Sandeep Kumar as Chief Operating Officer, effective May 11, 2026. The appointment, which also designates him an Officer of the Corporation and places him directly under the CEO, coincided with a roughly 5% rise in the company’s shares. Dr. Kumar brings more than 18 years of operations experience at Silicon Labs and prio…
MiNK Therapeutics announced clinical data demonstrating that its off-the-shelf, allogeneic iNKT cell therapy, agenT-797, triggers disease-appropriate immune responses without genetic modification. The same cell product activated pro-inflammatory responses in cancer patients and anti-inflammatory effects in ARDS patients from the same manufacturing …
PayPal trades at a low-teens to single-digit earnings multiple with $5.5B in free cash flow and an active buyback program. With margins already targeted by management to improve via cost cuts and share reduction, the stock offers a favorable risk-reward for a mid-term swing trade. Entry, stop and target included.
Collegium Pharmaceutical has finalized its acquisition of AZSTARYS, an ADHD medication, from Corium Therapeutics for approximately $650 million. The acquisition expands Collegium's ADHD product portfolio, leveraging existing commercial infrastructure to accelerate growth. The company has raised its 2026 financial guidance, expecting product revenue…
Two major Wall Street firms opened coverage of Aevex Corp this week with optimistic ratings, pointing to the drone maker's combat-proven product set and manufacturing scale as advantages as defense spending on autonomous systems increases. Analysts from Jefferies and Raymond James issued Buy-equivalent recommendations with price targets of $32 and …
